TGF-β upregulated ANGPTL4 in breast tumor cells and then disrupted the endothelial cell–cell junctions, leading to enhanced vascular leakiness and transendothelial migration of the tumor cells [9]. Here, ANGPTL4 is linked to breast neoplasm.